Cheng-Wen Chiang
Overview
Explore the profile of Cheng-Wen Chiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu M, Chiang C, Chiou A
Int J Nurs Stud
. 2020 Oct;
116:103778.
PMID: 33032795
Background: Self-care behaviour is important for patients with heart failure to prevent disease progression. More than half of patients have poor self-care behaviour. Self-regulation theory emphasizes that patients need to...
2.
Chang C, Chen Y, Ong E, Chen W, Chang C, Chen K, et al.
Clin Interv Aging
. 2016 Aug;
11:1123-8.
PMID: 27574412
Background: Percutaneous coronary intervention (PCI) has been widely used to treat acute coronary syndrome but is only recommended as an additional treatment to medical therapy and risk modification in patients...
3.
Yeh H, Kuo L, Sung F, Chiang C, Yeh C
Gene
. 2013 Apr;
523(1):64-9.
PMID: 23570881
Background And Objective: The genetic variants of xenobiotic-metabolizing enzymes, such as those encoded by glutathione-S-transferase (GST) genes, may be associated with the risk of coronary artery disease (CAD). To investigate...
4.
Santos R, Waters D, Tarasenko L, Messig M, Jukema J, Chiang C, et al.
Atherosclerosis
. 2012 Jul;
224(1):150-3.
PMID: 22818564
Objective: This study evaluated the success in attaining non-HDL-cholesterol (non-HDL-C) goals in the multinational L-TAP 2 study. Methods: 9955 patients ≥20 years of age with dyslipidemia on stable lipid-lowering therapy...
5.
Rodriguez F, Santos R, Messig M, Tarasenko L, Ferrieres J, Jukema J, et al.
Am J Cardiol
. 2012 Mar;
109(12):1738-42.
PMID: 22440124
There is a well-established link between dyslipidemia and cardiovascular events, although this risk is modified by age. Little is known about how treatment of dyslipidemia and low-density lipoprotein (LDL) cholesterol...
6.
Chang C, Lu W, Ong E, Chiang C, Lin S, Huang S, et al.
J Biomed Sci
. 2011 Dec;
18:93.
PMID: 22168157
Background: Platelet activation is relevant to a variety of coronary heart diseases. Our previous studies revealed that sesamol possesses potent antiplatelet activity through increasing cyclic AMP formation. Although platelets are...
7.
Chiang C, Santos R, Waters D, Messig M, Tarasenko L, Jukema J, et al.
Am J Cardiol
. 2011 Mar;
107(11):1639-43.
PMID: 21440886
The purpose of the present substudy of the Lipid Treatment Assessment Project 2 was to assess dual C-reactive protein (CRP) and low-density lipoprotein (LDL) cholesterol goal attainment across a spectrum...
8.
Jukema J, Chiang C, Ferrieres J, Santos R, Verdejo J, Waters D, et al.
Curr Med Res Opin
. 2010 Oct;
26(11):2589-97.
PMID: 20879831
Objective: This analysis of the Lipid Treatment Assessment Project 2 population compared lipid goal attainment by diabetes and metabolic syndrome status. Research Design And Methods: Dyslipidaemic patients aged ≥ 20...
9.
Chang C, Lee J, Chiang C, Jayakumar T, Hsiao G, Hsieh C, et al.
Pharm Biol
. 2010 Aug;
48(8):938-46.
PMID: 20673182
Content: Vascular smooth muscle cells (VSMCs) play a major role in the pathogenesis of atherosclerosis and restenosis, and thus the excessive proliferation of VSMCs contributes to neointimal thickening during atherosclerosis...
10.
Santos R, Waters D, Tarasenko L, Messig M, Jukema J, Ferrieres J, et al.
Am Heart J
. 2009 Oct;
158(5):860-6.
PMID: 19853709
Background: Differences between women and men have been documented for both diagnostic testing and treatment in cardiology. This analysis evaluates whether low-density lipoprotein cholesterol (LDL-C) success rates according to current...